Premium CJC-1295 with DAC | High-Purity Research Peptide | New Wave Peptides
Advance your laboratory studies with our premium CJC-1295 with DAC (Drug Affinity Complex). As a leading supplier of research-grade compounds, New Wave Peptides delivers this highly stable Growth Hormone-Releasing Hormone (GHRH) analog directly to your lab. Furthermore, we carefully test every batch to guarantee 99%+ purity. Consequently, this provides researchers with a reliable, consistent, and transparent foundation for studying endocrine and regenerative pathways.
What is CJC-1295 with DAC?
CJC-1295 operates as a synthetic analog of Growth Hormone-Releasing Hormone (GHRH). Specifically, the addition of the “DAC” (Drug Affinity Complex) serves as a crucial modification. By binding to albumin in the bloodstream, it significantly extends the peptide’s half-life from a few minutes to several days. As a result, researchers can study sustained, baseline elevations of growth hormone and IGF-1 without needing frequent, multiple daily administrations.
CJC-1295 with DAC Research Benefits
In preclinical and laboratory models, scientists extensively study CJC-1295 with DAC for its ability to modulate the somatotropic axis. Moreover, key areas of research include:
- Sustained GH and IGF-1 Elevation: Researchers utilize this compound to maintain prolonged, steady increases in growth hormone and insulin-like growth factor 1 (IGF-1) levels.
- Muscle Tissue & Recovery Models: Laboratories frequently apply this peptide to examine protein synthesis, muscle fiber repair, and recovery protocols following induced tissue stress.
- Adipose Tissue Metabolism: Scientists investigate its potential role in modulating lipolysis and supporting studies on body composition and metabolic rate.
- Enhanced Sleep Architecture Research: Additionally, researchers analyze the correlation between elevated growth hormone pulses and deep-wave (slow-wave) sleep cycles.
CJC-1295 with DAC Specifications: Purity, Composition, and Storage
When you source research materials, you demand exact data. Therefore, we provide comprehensive CJC-1295 with DAC specifications for every single batch. Specifically, our premium lyophilized powder guarantees top-tier quality and consistency for your laboratory studies. Furthermore, we formulate this product without any added fillers, preservatives, or man-made chemicals.
- Peptide Purity: >99% (We verify this strictly via High-Performance Liquid Chromatography and Mass Spectrometry).
- Molecular Weight: 3367.96 g/mol.
- Net Peptide Content: 2mg per vial.
- Appearance: A pristine white to off-white lyophilized powder.
- Amino Acid Sequence: [Specific sequence if applicable, or omit if proprietary].
- Storage Requirements: Store the unopened vial at -20°C to -8°C for maximum long-term stability. Once reconstituted, researchers must keep the solution refrigerated at 2°C to 8°C and utilize it within 21 to 30 days to maintain optimal integrity.
CJC-1295 with DAC Research Dosage & Protocols
Please note: The following information serves strictly educational and laboratory research purposes. It does not constitute medical advice.
Due to the extended half-life provided by the DAC molecule, research protocols for CJC-1295 with DAC differ significantly from its “no DAC” counterpart (Mod GRF 1-29). Typically, standard research models utilize dosages ranging from 1 mg to 2 mg per week. Often, scientists administer this as a single weekly injection or split it into two 0.5 mg to 1 mg doses. Therefore, researchers must carefully calculate reconstitution volumes based on the specific parameters of their study.
Potential Research Side Effects
Transparency remains critical in scientific research. While preclinical models generally tolerate CJC-1295 with DAC well, researchers should actively monitor for potential transient effects. These may include:
- Mild erythema (redness) or irritation at the subcutaneous injection site.
- Temporary water retention or mild edema in research subjects.
- Transient flushing or a mild increase in heart rate shortly after administration.
- Headaches or mild lethargy during the initial adaptation phase of the research protocol.
Why Choose New Wave Peptides for CJC-1295 with DAC?
The integrity of your research depends entirely on the purity of your compounds. Consequently, New Wave Peptides stands as the trusted choice for laboratories and researchers because we prioritize quality above all else:
- Verified 99%+ Purity: We test every vial using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry.
- Publicly Available COAs: Furthermore, we provide verifiable, batch-specific Certificates of Analysis (COAs) so you can confirm the exact purity and composition of your research materials.
- Superior Lyophilization: Our advanced freeze-drying process preserves the structural integrity of the peptide, thereby ensuring maximum stability and shelf life.
- Secure, Temperature-Controlled Shipping: Finally, we package your research materials with cold packs and ship them discreetly to guarantee they arrive in optimal condition.
Frequently Asked Questions: CJC-1295 with DAC
What is the difference between CJC-1295 with DAC and Mod GRF 1-29?
The primary difference lies in the peptide’s half-life and release mechanism. Specifically, CJC-1295 with DAC includes a Drug Affinity Complex (DAC) that binds to albumin in the bloodstream. Consequently, this extends the peptide’s half-life to several days, allowing researchers to study sustained, baseline elevations. On the other hand, Mod GRF 1-29 (CJC-1295 without DAC) lacks this complex and has a half-life of only about 30 minutes. Therefore, scientists use the DAC version for continuous elevation studies and the “no DAC” version for pulsatile release research.
What is the half-life of CJC-1295 with DAC?
Thanks to the Drug Affinity Complex (DAC) modification, this peptide boasts an extended half-life of approximately 6 to 8 days in research models. Because of this prolonged activity, researchers typically administer it much less frequently than peptides without the DAC modification, often utilizing once- or twice-weekly protocols.
How should I store CJC-1295 with DAC?
Proper storage ensures maximum peptide integrity. Before reconstitution, store the lyophilized powder in a freezer (-20°C) or a refrigerator (2°C to 8°C). Once you reconstitute the peptide with bacteriostatic water, you must keep the solution refrigerated (2°C to 8°C). Furthermore, researchers should use the reconstituted solution within 21 to 30 days to guarantee optimal results and prevent degradation.
How do you reconstitute CJC-1295 with DAC?
Proper handling protects the fragile amino acid chains. First, gather your sterile bacteriostatic water and a syringe. Next, gently direct the water stream down the side of the vial to avoid blasting the powder directly. Finally, swirl the vial gently—never shake it—until the powder completely dissolves into a clear solution.
Is it legal to buy CJC-1295 with DAC from New Wave Peptides?
Yes, absolutely. You can legally purchase CJC-1295 with DAC from New Wave Peptides strictly for in vitro laboratory research and development purposes. However, please note that this product is not approved for human consumption, clinical use, or veterinary application. Therefore, buyers must be qualified researchers operating in full compliance with their local, state, and federal laws.
Can I mix CJC-1295 with DAC with other research peptides?
In many laboratory settings, researchers frequently combine CJC-1295 with DAC with other compounds, such as Ipamorelin or GHRP-2, to study synergistic effects on the somatotropic axis. Nevertheless, when mixing peptides in a single syringe or vial, researchers must carefully calculate the concentrations and ensure the compounds remain stable in solution. Always consult peer-reviewed literature and standard operating procedures before combining research materials.
Legal & Research Disclaimer
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION.
New Wave Peptides strictly intends the provided CJC-1295 with DAC for in vitro laboratory research, development, and analytical testing. Specifically, this product does not constitute a dietary supplement, food, cosmetic, or pharmaceutical drug. Furthermore, the FDA (and MHRA in the UK) has not evaluated this product, and it does not diagnose, treat, cure, or prevent any disease. By purchasing this product, the buyer acknowledges their status as a qualified researcher or laboratory professional and agrees to use it solely in accordance with applicable local, state, and federal laws. Ultimately, New Wave Peptides assumes no liability for any misuse, improper handling, or adverse outcomes resulting from the use of this product. Keep out of reach of children and pets.
Reviews
There are no reviews yet.